NR3C2 and heart failure: Standard heart failure treatments, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and aldosterone receptor antagonists, improve myocardial remodeling, provide symptomatic relief, and prevent sudden cardiac death due to impaired cardiac function (14).